Mark C. Noe

Person

Mystic, CT, US

People

Patents Grantslast 30 patents

Information Patent Grant
Isothiazole derivatives useful as anticancer agents
- Patent number 7,790,902
- Issue date Sep 7, 2010
- Pfizer, Inc.
- Eric R. Larson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Macrolides
- Patent number 7,462,600
- Issue date Dec 9, 2008
- Pfizer Inc.
- Louis S. Chupak
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isothiazole derivatives useful as anticancer agents
- Patent number 7,405,218
- Issue date Jul 29, 2008
- Pfizer, Inc.
- Eric R. Larson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Selective inhibition of aggrecanase in osteoarthritis treatment
- Patent number 7,030,242
- Issue date Apr 18, 2006
- Pfizer Inc.
- Mark C. Noe
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N-substituted-heteroaryloxy-aryloxy-pyrimidine-2,4,6-trione metallo...
- Patent number 6,919,332
- Issue date Jul 19, 2005
- Pfizer Inc.
- Mark C. Noe
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Triaryl-oxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase in...
- Patent number 6,916,807
- Issue date Jul 12, 2005
- Pfizer Inc.
- Kevin D. Freeman-Cook
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione meta...
- Patent number 6,900,201
- Issue date May 31, 2005
- Pfizer Inc.
- Mark C. Noe
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
- Patent number 6,841,671
- Issue date Jan 11, 2005
- Pfizer Inc.
- Mark C. Noe
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrimidine-2,4,6-trione metalloproteinase inhibitors
- Patent number 6,706,723
- Issue date Mar 16, 2004
- Pfizer, Inc.
- Mark C. Noe
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Gem substituted hydroxamic acids
- Patent number 6,608,104
- Issue date Aug 19, 2003
- Pfizer Inc.
- Mark C. Noe
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Arylsulfonyl hydroxamic acid derivatives
- Patent number 6,599,890
- Issue date Jul 29, 2003
- Pfizer Inc.
- Kim F. McClure
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isothiazole derivatives useful as anticancer agents
- Patent number 6,548,526
- Issue date Apr 15, 2003
- Pfizer Inc.
- Eric R. Larson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic derivatives useful as anticancer agents
- Patent number 6,380,214
- Issue date Apr 30, 2002
- Pfizer Inc.
- Thomas George Gant
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hydroxy pipecolate hydroxamic acid derivatives
- Patent number 6,329,397
- Issue date Dec 11, 2001
- Pfizer
- Kim F. McClure
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isothiazole derivatives useful as anticancer agents
- Patent number 6,235,764
- Issue date May 22, 2001
- Pfizer Inc.
- Eric R. Larson
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
Isothiazole Derivatives Useful as Anticancer Agents
- Publication number 20080300249
- Publication date Dec 4, 2008
- Pfizer, Inc.
- Eric R. Larson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MACROLIDES
- Publication number 20080293646
- Publication date Nov 27, 2008
- Pfizer Inc.
- Thomas V. Magee
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Macrolides
- Publication number 20060135447
- Publication date Jun 22, 2006
- Louis S. Chupak
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Selective inhibition of aggrecanase in osteoarthritis treatment
- Publication number 20050227997
- Publication date Oct 13, 2005
- Mark C. Noe
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TACE inhibitors
- Publication number 20050215549
- Publication date Sep 29, 2005
- Kim F. McClure
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
- Publication number 20050159413
- Publication date Jul 21, 2005
- Mark C. Noe
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyrimidine-2,4,6-trione metalloproteinase inhibitors
- Publication number 20050107414
- Publication date May 19, 2005
- Mark C. Noe
- C07 - ORGANIC CHEMISTRY
Information Patent Application
N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione meta...
- Publication number 20040010141
- Publication date Jan 15, 2004
- Pfizer Inc.
- Mark C. Noe
- C07 - ORGANIC CHEMISTRY
Information Patent Application
N-substituted-heteroaryloxy-aryloxy-pyrimidine-2,4,6-trione metallo...
- Publication number 20030232849
- Publication date Dec 18, 2003
- Pfizer Inc.
- Mark C. Noe
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Triaryl-oxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase in...
- Publication number 20030225056
- Publication date Dec 4, 2003
- Pfizer Inc.
- Kevin D. Freeman-Cook
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TACE INHIBITORS
- Publication number 20030181441
- Publication date Sep 25, 2003
- KIM MCCLURE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Isothiazole derivatives useful as anticancer agents
- Publication number 20030149048
- Publication date Aug 7, 2003
- Pfizer Inc.
- Eric R. Larson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors
- Publication number 20030096803
- Publication date May 22, 2003
- Mark C. Noe
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Hydroxy pipecolate hydroxamic acid derivatives
- Publication number 20030008901
- Publication date Jan 9, 2003
- Kim F. McClure
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyrimidine-2,4,6-trione metalloproteinase inhibitors
- Publication number 20020132822
- Publication date Sep 19, 2002
- Mark C. Noe
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Gem substituted hydroxamic acids
- Publication number 20020019534
- Publication date Feb 14, 2002
- Mark C. Noe
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Isothiazole derivatives useful as anticancer agents
- Publication number 20010020034
- Publication date Sep 6, 2001
- Eric R. Larson
- C07 - ORGANIC CHEMISTRY

Mark C. Noe

Person

Patents Grantslast 30 patents

Isothiazole derivatives useful as anticancer agents

Macrolides

Isothiazole derivatives useful as anticancer agents

Selective inhibition of aggrecanase in osteoarthritis treatment

N-substituted-heteroaryloxy-aryloxy-pyrimidine-2,4,6-trione metallo...

Triaryl-oxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase in...

N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione meta...

Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors

Pyrimidine-2,4,6-trione metalloproteinase inhibitors

Gem substituted hydroxamic acids

Arylsulfonyl hydroxamic acid derivatives

Isothiazole derivatives useful as anticancer agents

Heterocyclic derivatives useful as anticancer agents

Hydroxy pipecolate hydroxamic acid derivatives

Isothiazole derivatives useful as anticancer agents

Patents Applicationslast 30 patents

Isothiazole Derivatives Useful as Anticancer Agents

MACROLIDES

Macrolides

Selective inhibition of aggrecanase in osteoarthritis treatment

TACE inhibitors

Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors

Pyrimidine-2,4,6-trione metalloproteinase inhibitors

N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione meta...

N-substituted-heteroaryloxy-aryloxy-pyrimidine-2,4,6-trione metallo...

Triaryl-oxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase in...

TACE INHIBITORS

Isothiazole derivatives useful as anticancer agents

Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors

Hydroxy pipecolate hydroxamic acid derivatives

Pyrimidine-2,4,6-trione metalloproteinase inhibitors

Gem substituted hydroxamic acids

Isothiazole derivatives useful as anticancer agents